In today’s recent session, 0.41 million shares of the Sana Biotechnology Inc (NASDAQ:SANA) have been traded, and its beta is 1.41. Most recently the company’s share price was $4.13, and it changed around -$0.1 or -2.36% from the last close, which brings the market valuation of the company to $918.87M. SANA at last check was trading at a discount to its 52-week high of $12.00, offering almost -190.56% off that amount. The share price’s 52-week low was $2.74, which indicates that the recent value has risen by an impressive 33.66% since then. We note from Sana Biotechnology Inc’s average daily trading volume that its 10-day average is 1.67 million shares, with the 3-month average coming to 1.59 million.
Sana Biotechnology Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.67. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended SANA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Sana Biotechnology Inc is expected to report earnings per share of -0.27 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA has been showing red trend so far today with a performance of -2.36% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.43 on recent trading dayincreased the stock’s daily price by 6.77%. The company’s shares are currently up 1.23% year-to-date, but still down -0.71% over the last five days. On the other hand, Sana Biotechnology Inc (NASDAQ:SANA) is -18.05% down in the 30-day period. We can see from the shorts that 31.17 million shares have been sold at a short interest cover period of 22.79 day(s).
The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to increase their stock price by 65.58% from its current value. Analyst projections state that SANA is forecast to be at a low of $12 and a high of $12.
Sana Biotechnology Inc (SANA) estimates and forecasts
Sana Biotechnology Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -54.56 percent over the past six months and at a 27.61% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -1,450.00% in revenue this quarter, and will report an increase of 39.00% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -83.13%.
SANA Dividends
Sana Biotechnology Inc’s next quarterly earnings report is expected to be released on 2024-Nov-06.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.60% of Sana Biotechnology Inc shares, and 90.39% of them are in the hands of institutional investors. The stock currently has a share float of 98.89%. Sana Biotechnology Inc stock is held by 213.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 12.5041% of the shares, which is about 27.17 million shares worth $148.35 million.
FLAGSHIP PIONEERING INC., with 11.5062% or 25.0 million shares worth $136.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
